Navigation Links
ImmunoCellular Therapeutics Issues Shareholder Letter Providing Update on ICT-107 Program in Newly Diagnosed Glioblastoma
Date:1/9/2014

LOS ANGELES, Jan. 9, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today issued the following letter to shareholders providing an update on the Company's ICT-107 clinical program in patients with newly diagnosed glioblastoma (GBM).

(Logo:  http://photos.prnewswire.com/prnh/20140109/AQ43875LOGO)

To Our Shareholders:

Since the December 11, 2013 announcement of results from the exploratory phase II trial of ICT-107, we have continued to analyze the data set from the trial and consulted with experts in the field of neuro-oncology with the goal of informing our next development and regulatory activities for this program. We would like to update shareholders on three key topics:

  • Our determination that overall survival (OS) was the appropriate primary endpoint for our development program. Although we did not meet the OS endpoint, we are enthusiastic about meeting our progression free survival (PFS) endpoint because we think it supports the presence of an OS signal, which may clarify, and potentially strengthen, as we collect more survival data;
  • Our review of additional immunological data from the trial. To date, we have found two hallmark indicators of dendritic cell activation in the ICT-107 vaccines that are predictive of survival benefit. This finding is important to developing manufacturing assays and informing our phase III trial design; and
  • Our plan, in the next two to three quarters, to communicate additional phase II trial data, and to meet with the US FDA and the European Medicines Agency (EMA) to discuss next steps in the development of ICT-107.

The primary goals of this exploratory trial were to assess safety and the effect that ICT-107 has on clinical outcomes in patients with newly diagnosed GBM, and t
'/>"/>

SOURCE ImmunoCellular Therapeutics, Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... -- PuraMed BioScience®, Inc., (OTC Pink: PMBS), a researcher, ... products, announced it received the initial funding to begin ... relief product, for planned distribution to 1,000 medical and ... Washington State , and ... Advanced headache relief gel formulation completed, PuraMed BioScience has ...
(Date:12/24/2014)... 2014 LifeScienceIndustryResearch.com adds ... Syringe Industry of 178 pages providing 10 ... library. The 2014 Market Research ... a professional and deep research report on ... the report introduces Disposable Syringe basic information ...
(Date:12/24/2014)... 23, 2014  The American Diabetes Association is ... for people with diabetes and that all people ... of statins, in keeping with recent changes to ... American College of Cardiology (ACC) and American Heart ... most recent changes to the Association,s annual revised ...
Breaking Medicine Technology:PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4
... Card, in partnership with The Denver Metro Chamber, announced ... "Preferred Pharmacy" for the program. As part of the ... Drug Card. Coloradans can simply walk into any Walgreens ... through the Colorado Drug Card. Walgreens will also have ...
... a world leading provider of scientific, technical and medical ... today honor eight early career researchers in a range ... Young Researcher Award ceremony. More than 80 university ... attend the award ceremony at the Royal Society in ...
Cached Medicine Technology:Elsevier and the Fulbright Commission Honor UK Research Talent With the UK Scopus Young Researcher Award 2Elsevier and the Fulbright Commission Honor UK Research Talent With the UK Scopus Young Researcher Award 3Elsevier and the Fulbright Commission Honor UK Research Talent With the UK Scopus Young Researcher Award 4
(Date:12/26/2014)... It is said that nothing makes a ... the famous wedding dress supplier, shows its new selection ... gown promotion. , UWDress.com’s navy cocktail gowns are the ... in high fashion styles. Simple dresses in bright neon colors ... they are specially designed for those who want to shine ...
(Date:12/26/2014)... (PRWEB) December 26, 2014 Plugin and template ... TransPack Volume 5 Plugin for Final Cut Pro X. , ... hard light tool to pull off an industry professional look” ... get their hands on TransPack Volume 5, a new level ... is a set of over 50 Final Cut Pro X ...
(Date:12/26/2014)... (DaWei Induction Heating Co.) is a comprehensive high-tech business ... of a series of induction heating equipment. Today, the ... induction brazing equipments . , According to a ... refers to the joining of two or more components ... says that there are fundamental differences in the two ...
(Date:12/25/2014)... 2014 The click strand ... strength and durability. Today, the business announces a ... valid until Jan. 30, 2015. , Click strand ... hardwood. BambooFlooringChina.com is a well-known brand in the ... to find a reliable bamboo flooring supplier. , ...
(Date:12/25/2014)... December 26, 2014 “Every three months the ... changes. A-line sweetheart evening dress will be one of the ... manager of Yunx.co.uk says. Today, the company releases 26 A-line ... up to 80% off. , “We are trying our ... style with our latest designs. Along with affordable prices, we ...
Breaking Medicine News(10 mins):Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2Health News:Today a new plugin was announced from Pixel Film Studios, TransPack Volume 5 for Final Cut Pro X 2Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2
... The March for Babies 2008 Official Shoes are Now On ... of,Dimes has teamed up with Famous Footwear(TM) and Dr. Scholl,s(R) ... For the third consecutive year, Famous Footwear and Dr. Scholl,s ... walking shoe styles.,Dr. Scholl,s specially designed one men,s and two ...
... Dialysis Corporation,of America (Nasdaq: DCAI ) announced today ... year financial results on March 13, 2008, after the,close ... conference calls,in conjunction with its quarterly earnings releases, beginning ... following morning, March 14,2008 at 10:00 AM EDT., ...
... JERSEY, FEBRUARY 29 -- Otsuka Pharmaceutical Co., Ltd. and ... U.S. Food and Drug Administration (FDA) approved the supplemental ... treatment of manic and mixed episodes associated with Bipolar ... patients (10 to 17 years old). ABILIFY has ...
... study in the Mojave Desert, Calif., has found that soils ... a type of salt, close to the surface. Vulnerable to ... disrupted, this vast source of nitrate could contaminate surface and ... appear in the March issue of Geology . , ...
... of Hematology announce a new partnership to publish the ... available (back to 1997) on Springers online information platform ... and was previously published by Carden Jennings. , Since ... official journal of the Japanese Society of Hematology (JSH), ...
... ATLANTA, Feb. 29 Children,s Healthcare of Atlanta, ... today a,landmark investment in the future of pediatric ... $430 million of the Children,s,endowment toward pediatric research., ... will be,invested in pediatric research," said James E. ...
Cached Medicine News:Health News:Famous Footwear, Dr. Scholl's Step Up to Support March for Babies 2008 2Health News:Dialysis Corporation of America Announces Fiscal Year 2007 Earnings Release Date 2Health News:ABILIFY approved for acute treatment of bipolar I disorder in patients 10 to 17 years old 2Health News:ABILIFY approved for acute treatment of bipolar I disorder in patients 10 to 17 years old 3Health News:ABILIFY approved for acute treatment of bipolar I disorder in patients 10 to 17 years old 4Health News:Large source of nitrate, a potential water contaminant, found in near-surface desert soils 2Health News:Large source of nitrate, a potential water contaminant, found in near-surface desert soils 3Health News:Springer to publish International Journal of Hematology 2Health News:Children's Healthcare of Atlanta Announces Major Investment in Pediatric Research as Part of 10-Year Vision 2Health News:Children's Healthcare of Atlanta Announces Major Investment in Pediatric Research as Part of 10-Year Vision 3
Jewelers forceps. Insulated....
Semkin forceps with stops. Insulated....
Gerald bayonet forceps. Insulated....
Cushing forceps. Insulated....
Medicine Products: